InvestorsHub Logo
Followers 33
Posts 2835
Boards Moderated 2
Alias Born 10/24/2015

Re: longfellow95 post# 393959

Thursday, 08/05/2021 5:23:41 PM

Thursday, August 05, 2021 5:23:41 PM

Post# of 698817
Not for TIL. In 'cold' types, Dr. Rosenberg has reported an ORR of 12% using neoantigen reactive and it almost doubles with an added anti-PD-1 (up to four doses of Keytruda). With better selection (CD39-CD69-CD8+* and eventually certain CD4+ population(s)) and ex vivo expansion, the ORR should improve.

* Associated with complete responses https://science.sciencemag.org/content/370/6522/1328
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News